{"id":8818,"date":"2024-04-26T02:39:08","date_gmt":"2024-04-26T02:39:08","guid":{"rendered":"https:\/\/economicherald.net\/?p=8818"},"modified":"2024-04-26T02:39:08","modified_gmt":"2024-04-26T02:39:08","slug":"asx-health-stocks-recce-can-now-dose-r327-at-higher-level-testing-its-high-concentration-potential","status":"publish","type":"post","link":"https:\/\/economicherald.net\/?p=8818","title":{"rendered":"ASX Health Stocks: Recce can now dose R327 at higher level, testing its high concentration potential"},"content":{"rendered":"<p>Recce Pharma cleared to increase R327\u2019s minimum dose<br \/>\nR327 can now be administered at 4,000mg over a fast infusion of 30 minutes<br \/>\nResMed has had a solid Q3<\/p>\n<p>\u00a0<\/p>\n<h2>Recce Pharma cleared to increase drug dose<\/h2>\n<p><strong><a href=\"https:\/\/stockhead.com.au\/company\/recce-pharmaceuticals-rce\/\">Recce Pharmaceuticals (ASX:RCE)<\/a><\/strong> says an independent <em>Safety Committee<\/em> has unanimously cleared an increase of <strong>Recce327 (R327)<\/strong> to <strong>4,000mg (I.V.) over a fast infusion of 30 minutes.<\/strong><\/p>\n<p>The approval came after the company has previously tested dosing at 3,000mg at multiple infusion times; 15 mins, 20 mins, 30 mins, 45 mins, and 1 hour.<\/p>\n<p>Recce has now identified 30 minutes as the potential optimum infusion time for 4,000mg, as the company investigates R327\u2019s high concentration potential.<\/p>\n<p>R327 is one of Recce\u2019s anti-infective pipelines used as an intravenous and topical therapy being developed for the treatment of serious and potentially life-threatening infections.<\/p>\n<p>The drug is currently being studied in the ongoing <em>Phase I\/II study<\/em> of the IV formulation in healthy volunteers and in patients with uncomplicated or recurrent <strong>urinary tract infections (UTIs).<\/strong><\/p>\n<p>In a parallel clinical program, R327 applied topically against Diabetic Foot Ulcer Infections recently demonstrated its efficacious potential against a broad range of antibiotic-resistant infections.<\/p>\n<p>The potential of R327 via I.V. administration will now be made available at the completion of this human clinical trial in line with study protocol.<\/p>\n<p><strong>CEO James Graham<\/strong> says he\u2019s thrilled the independent safety committee has unanimously clearly an increased R327 dose to 4,000mg, over a 30-minute fast I.V. infusion.<\/p>\n<p>\u201cThe high concentration potential to administer a broad spectrum anti-infective underscores the potential of a novel treatment for millions of patients worldwide that suffer from Urinary Tract Infection\/Urosepsis each year,\u201d Graham said.<\/p>\n<p>\u00a0<\/p>\n<h2>ResMed has had a solid quarter<\/h2>\n<p>Meanwhile, sleep device and digital health company <strong><a href=\"https:\/\/stockhead.com.au\/company\/resmed-rmd\/\">ResMed (ASX:RMD)<\/a><\/strong> has had a solid Q3 FY24.<\/p>\n<p>In the quarter, revenue increased by 7% on pcp to $1.2 billion.<\/p>\n<p>Gross margin grew 260 bps to 57.9%; and income from operations increased 25% to $374.6m.<\/p>\n<p>During the quarter, ResMed paid $70 million in dividends and repurchased 261,000 shares for a total of $50 million as part of its ongoing capital management.<\/p>\n<p>\u00a0<\/p>\n<h2>Share prices today:<\/h2>\n<p>\u00a0<\/p>\n\n<p><span class=\"mce_SELRES_start\">\ufeff<\/span><span class=\"mce_SELRES_start\"><\/span>\u00a0<br \/>\n<span class=\"et_bloom_bottom_trigger\"><\/span><\/p>\n<p>The post <a href=\"https:\/\/stockhead.com.au\/health\/asx-health-stocks-recce-can-now-dose-r327-at-higher-level-testing-its-high-concentration-potential\/\">ASX Health Stocks: Recce can now dose R327 at higher level, testing its high concentration potential<\/a> appeared first on <a href=\"https:\/\/stockhead.com.au\/\">Stockhead<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"<p>Recce Pharma cleared to increase R327\u2019s minimum dose R327 can now be administered at 4,000mg over a fast infusion of 30 minutes ResMed has had <a href=\"https:\/\/economicherald.net\/?p=8818\" class=\"read-more-link\">[more&#8230;]<\/a><\/p>\n","protected":false},"author":0,"featured_media":8819,"comment_status":"","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-8818","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-finance"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ASX Health Stocks: Recce can now dose R327 at higher level, testing its high concentration potential - Economic Herald<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/economicherald.net\/?p=8818\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ASX Health Stocks: Recce can now dose R327 at higher level, testing its high concentration potential - Economic Herald\" \/>\n<meta property=\"og:description\" content=\"Recce Pharma cleared to increase R327\u2019s minimum dose R327 can now be administered at 4,000mg over a fast infusion of 30 minutes ResMed has had [more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/economicherald.net\/?p=8818\" \/>\n<meta property=\"og:site_name\" content=\"Economic Herald\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-26T02:39:08+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=8818#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=8818\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"ASX Health Stocks: Recce can now dose R327 at higher level, testing its high concentration potential\",\"datePublished\":\"2024-04-26T02:39:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=8818\"},\"wordCount\":382,\"publisher\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=8818#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/Safety-Committee-clears-Recce327-to-be-administered-at-higher-dose.-Picture-Getty-YrVhJx.jpeg\",\"articleSection\":[\"Finance\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=8818\",\"url\":\"https:\\\/\\\/economicherald.net\\\/?p=8818\",\"name\":\"ASX Health Stocks: Recce can now dose R327 at higher level, testing its high concentration potential - Economic Herald\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=8818#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=8818#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/Safety-Committee-clears-Recce327-to-be-administered-at-higher-dose.-Picture-Getty-YrVhJx.jpeg\",\"datePublished\":\"2024-04-26T02:39:08+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=8818#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/economicherald.net\\\/?p=8818\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=8818#primaryimage\",\"url\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/Safety-Committee-clears-Recce327-to-be-administered-at-higher-dose.-Picture-Getty-YrVhJx.jpeg\",\"contentUrl\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/Safety-Committee-clears-Recce327-to-be-administered-at-higher-dose.-Picture-Getty-YrVhJx.jpeg\",\"width\":1200,\"height\":675},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=8818#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/economicherald.net\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ASX Health Stocks: Recce can now dose R327 at higher level, testing its high concentration potential\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/#website\",\"url\":\"https:\\\/\\\/economicherald.net\\\/\",\"name\":\"Economic Herald\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/economicherald.net\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/#organization\",\"name\":\"Economic Herald\",\"url\":\"https:\\\/\\\/economicherald.net\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/cropped-cropped-economicheraldlogo-1.png\",\"contentUrl\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/cropped-cropped-economicheraldlogo-1.png\",\"width\":850,\"height\":760,\"caption\":\"Economic Herald\"},\"image\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ASX Health Stocks: Recce can now dose R327 at higher level, testing its high concentration potential - Economic Herald","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/economicherald.net\/?p=8818","og_locale":"en_US","og_type":"article","og_title":"ASX Health Stocks: Recce can now dose R327 at higher level, testing its high concentration potential - Economic Herald","og_description":"Recce Pharma cleared to increase R327\u2019s minimum dose R327 can now be administered at 4,000mg over a fast infusion of 30 minutes ResMed has had [more...]","og_url":"https:\/\/economicherald.net\/?p=8818","og_site_name":"Economic Herald","article_published_time":"2024-04-26T02:39:08+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/economicherald.net\/?p=8818#article","isPartOf":{"@id":"https:\/\/economicherald.net\/?p=8818"},"author":{"name":"","@id":""},"headline":"ASX Health Stocks: Recce can now dose R327 at higher level, testing its high concentration potential","datePublished":"2024-04-26T02:39:08+00:00","mainEntityOfPage":{"@id":"https:\/\/economicherald.net\/?p=8818"},"wordCount":382,"publisher":{"@id":"https:\/\/economicherald.net\/#organization"},"image":{"@id":"https:\/\/economicherald.net\/?p=8818#primaryimage"},"thumbnailUrl":"https:\/\/economicherald.net\/wp-content\/uploads\/2024\/04\/Safety-Committee-clears-Recce327-to-be-administered-at-higher-dose.-Picture-Getty-YrVhJx.jpeg","articleSection":["Finance"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/economicherald.net\/?p=8818","url":"https:\/\/economicherald.net\/?p=8818","name":"ASX Health Stocks: Recce can now dose R327 at higher level, testing its high concentration potential - Economic Herald","isPartOf":{"@id":"https:\/\/economicherald.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/economicherald.net\/?p=8818#primaryimage"},"image":{"@id":"https:\/\/economicherald.net\/?p=8818#primaryimage"},"thumbnailUrl":"https:\/\/economicherald.net\/wp-content\/uploads\/2024\/04\/Safety-Committee-clears-Recce327-to-be-administered-at-higher-dose.-Picture-Getty-YrVhJx.jpeg","datePublished":"2024-04-26T02:39:08+00:00","breadcrumb":{"@id":"https:\/\/economicherald.net\/?p=8818#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/economicherald.net\/?p=8818"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/economicherald.net\/?p=8818#primaryimage","url":"https:\/\/economicherald.net\/wp-content\/uploads\/2024\/04\/Safety-Committee-clears-Recce327-to-be-administered-at-higher-dose.-Picture-Getty-YrVhJx.jpeg","contentUrl":"https:\/\/economicherald.net\/wp-content\/uploads\/2024\/04\/Safety-Committee-clears-Recce327-to-be-administered-at-higher-dose.-Picture-Getty-YrVhJx.jpeg","width":1200,"height":675},{"@type":"BreadcrumbList","@id":"https:\/\/economicherald.net\/?p=8818#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/economicherald.net\/"},{"@type":"ListItem","position":2,"name":"ASX Health Stocks: Recce can now dose R327 at higher level, testing its high concentration potential"}]},{"@type":"WebSite","@id":"https:\/\/economicherald.net\/#website","url":"https:\/\/economicherald.net\/","name":"Economic Herald","description":"","publisher":{"@id":"https:\/\/economicherald.net\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/economicherald.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/economicherald.net\/#organization","name":"Economic Herald","url":"https:\/\/economicherald.net\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/economicherald.net\/#\/schema\/logo\/image\/","url":"https:\/\/economicherald.net\/wp-content\/uploads\/2023\/10\/cropped-cropped-economicheraldlogo-1.png","contentUrl":"https:\/\/economicherald.net\/wp-content\/uploads\/2023\/10\/cropped-cropped-economicheraldlogo-1.png","width":850,"height":760,"caption":"Economic Herald"},"image":{"@id":"https:\/\/economicherald.net\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/economicherald.net\/index.php?rest_route=\/wp\/v2\/posts\/8818","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/economicherald.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/economicherald.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/economicherald.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=8818"}],"version-history":[{"count":0,"href":"https:\/\/economicherald.net\/index.php?rest_route=\/wp\/v2\/posts\/8818\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/economicherald.net\/index.php?rest_route=\/wp\/v2\/media\/8819"}],"wp:attachment":[{"href":"https:\/\/economicherald.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=8818"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/economicherald.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=8818"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/economicherald.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=8818"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}